Published in BMC Res Notes on September 01, 2012
Disorders of sex development: effect of molecular diagnostics. Nat Rev Endocrinol (2015) 0.90
Exome Sequencing in Fetuses with Structural Malformations. J Clin Med (2014) 0.85
Prenatal sex determination in suspicious cases of X-linked recessive diseases by the amelogenin gene. Iran J Basic Med Sci (2014) 0.75
Discrepancy in fetal sex assignment between cell free fetal DNA and ultrasound. J Perinatol (2015) 0.75
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol (2005) 10.56
Presence of fetal DNA in maternal plasma and serum. Lancet (1997) 9.01
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A (2008) 8.38
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet (1998) 6.88
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 5.94
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med (2010) 5.54
Genetic disorders in children and young adults: a population study. Am J Hum Genet (1988) 4.98
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet (1999) 3.39
Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem (2004) 2.79
Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol (2007) 2.55
Controversies in meta-analysis: the case of the trials of serum cholesterol reduction. Stat Methods Med Res (1993) 2.22
Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem (1999) 1.65
Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA (2011) 1.59
Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn (2007) 1.46
Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem (2005) 1.27
Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem (2004) 1.23
Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion (2007) 1.20
Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet (2010) 1.16
Maternal plasma fetal DNA as a marker for preterm labour. Lancet (1998) 1.16
First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn (2001) 1.13
Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod (2003) 1.10
Fetal DNA detection in maternal plasma throughout gestation. Hum Genet (2005) 1.09
Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet (2001) 1.04
Molecular prenatal diagnosis: the impact of modern technologies. Prenat Diagn (2010) 1.01
Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol (2001) 1.00
Quantity versus quality: optimal methods for cell-free DNA isolation from plasma of pregnant women. Genet Med (2006) 0.99
Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia (2008) 0.99
Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG (2000) 0.99
Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol (2004) 0.98
Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update (2002) 0.97
Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination. Prenat Diagn (2003) 0.97
Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem (2001) 0.96
Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics (2010) 0.96
Non-invasive fetal sex determination using a conventional nested PCR analysis of fetal DNA in maternal plasma. Clin Chim Acta (2003) 0.95
Chimeric LNA/DNA probes as a detection system for real-time PCR. Clin Biochem (2004) 0.95
Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev (2007) 0.95
Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly (2001) 0.93
Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet (2000) 0.93
Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn (2003) 0.92
Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn (2005) 0.91
Evaluation of different approaches for fetal DNA analysis from maternal plasma and nucleated blood cells. Clin Chem (1999) 0.90
Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels. Reprod Sci (2008) 0.90
Successful diagnosis of fetal gender using conventional PCR analysis of maternal serum. Clin Chem (2001) 0.90
Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clin Chem (2009) 0.90
Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion (2005) 0.89
Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diagn (2001) 0.89
High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood. Fetal Diagn Ther (2000) 0.89
Noninvasive genotyping of 9 Y-chromosome specific STR loci using circulatory fetal DNA in maternal plasma by multiplex PCR. Prenat Diagn (2006) 0.89
Prenatal fetal sex diagnosis by detecting amelogenin gene in maternal plasma. Prenat Diagn (2005) 0.88
Circulating cell-free DNA levels increase variably following chorionic villus sampling. Prenat Diagn (2010) 0.88
Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels. Prenat Diagn (2008) 0.86
Detecting fetal DNA from dried maternal blood spots: another step towards broad scale non-invasive prenatal genetic screening and feasible testing. Reprod Biomed Online (2003) 0.85
Non-invasive foetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma. Eur J Clin Invest (2009) 0.84
The best approach for early prediction of fetal gender by using free fetal DNA from maternal plasma. Prenat Diagn (2008) 0.84
Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol (2000) 0.84
Clinical applications of fetal sex determination in maternal blood in a preimplantation genetic diagnosis centre. Hum Reprod (2002) 0.83
Y chromosome detection by Real Time PCR and pyrophosphorolysis-activated polymerisation using free fetal DNA isolated from maternal plasma. Prenat Diagn (2007) 0.83
Prenatal identification of fetal genetic traits. Lancet (2001) 0.83
Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn (2006) 0.82
First-trimester fetal sex prediction by deoxyribonucleic acid analysis of maternal peripheral blood. Am J Obstet Gynecol (1999) 0.82
Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid. Arch Gynecol Obstet (2005) 0.82
Non-invasive fetal sex determination using real-time PCR. J Matern Fetal Neonatal Med (2006) 0.82
Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang (2003) 0.81
Non-invasive first trimester fetal gender assignment in pregnancies at risk for X-linked recessive diseases. Prenat Diagn (2002) 0.81
Maldi-tof mass spectrometry compared with real-time PCR for detection of fetal cell-free DNA in maternal plasma. Clin Chem (2006) 0.81
Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis. Acta Obstet Gynecol Scand (2007) 0.81
Non-invasive prenatal diagnosis of fetal gender using real-time polymerase chain reaction amplification of SRY in maternal plasma. Ann Acad Med Singapore (2004) 0.81
Detection of cell-free fetal DNA in maternal urine. Prenat Diagn (2006) 0.80
Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester. Obstet Gynecol (2007) 0.80
Analysis of cell-free fetal DNA in plasma and serum of pregnant women. J Histochem Cytochem (2005) 0.80
Application of fetal DNA in maternal plasma in noninvasive prenatal diagnosis. J Huazhong Univ Sci Technolog Med Sci (2004) 0.80
Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester. Prenat Diagn (2007) 0.80
Detection of fetal DNA in maternal plasma by microarray coupled with emulsions PCR. Clin Chim Acta (2006) 0.80
Fetal origin of single nucleated erythroblasts and free DNA in the peripheral blood of pregnant women. Int J Gynaecol Obstet (2004) 0.79
Fetal gender determination using real-time quantitative polymerase chain reaction analysis of maternal plasma. J Formos Med Assoc (2004) 0.79
[Study on fetal SRY gene in maternal plasma using nested polymerase chain reaction]. Zhonghua Nan Ke Xue (2006) 0.79
Feasibility study for a microchip-based approach for noninvasive prenatal diagnosis of genetic diseases. Ann N Y Acad Sci (2004) 0.78
Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe. Mol Hum Reprod (2006) 0.78
Accuracy of fetal gender determination in maternal plasma at 5 and 6 weeks of pregnancy. Prenat Diagn (2006) 0.78
Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia (2006) 0.78
Detection and quantification by homogeneous PCR of cell-free fetal DNA in maternal plasma. Clin Chem (2001) 0.77
Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis. Transfusion (2008) 0.77
Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia. BJOG (2006) 0.77
Analysis of multiple loci can increase reliability of detection of fetal Y-chromosome DNA in maternal plasma. Prenat Diagn (2008) 0.77
Accuracy of fetal gender detection using a conventional nested PCR assay of maternal plasma in daily practice. Aust N Z J Obstet Gynaecol (2008) 0.77
Comparison of PCR methods for detecting fetal RhDin maternal plasma. J Clin Lab Anal (2009) 0.77
Non-invasive first-trimester detection of paternal beta-globin gene mutations and polymorphisms as predictors of thalassemia risk at chorionic villous sampling. Eur J Obstet Gynecol Reprod Biol (2008) 0.77
Examination of fetal cells and cell-free fetal DNA in maternal blood for fetal gender determination. Gynecol Obstet Invest (2004) 0.77
Gene analysis of free fetal DNA in maternal plasma. J Tongji Med Univ (2001) 0.77
[Fetal sex determination with real time PCR of fetal DNA in maternal plasma]. Orv Hetil (2003) 0.77
[Application of fetal DNA in maternal plasma for non-invasive prenatal diagnosis of fetal sex]. Yi Chuan (2004) 0.76
Detection of fetal sex in the peripheral blood of pregnant women. Fetal Diagn Ther (2007) 0.76
[Noninvasive fetal sex detection from maternal plasma in pregnant women]. Ceska Gynekol (2008) 0.76
Fetal sex identification in maternal plasma by means of short tandem repeats on chromosome x. Ann N Y Acad Sci (2008) 0.76
Quantitative analysis of DNA levels in maternal plasma in normal and Down syndrome pregnancies. BMC Pregnancy Childbirth (2002) 0.76
[Detection of fetal DNA in maternal plasma using the nested polymerase chain reaction]. Zhonghua Fu Chan Ke Za Zhi (1999) 0.76
Influence of gestational age on fetal deoxyribonucleic acid retrieval in maternal peripheral blood. Am J Obstet Gynecol (1997) 0.76
[Detection of fetal SRY gene in maternal plasma by real-time fluorescence quantitative PCR]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2004) 0.75
Fetal DNA in maternal serum: does it persist after pregnancy? Hum Genet (2003) 0.75
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol (2007) 7.00
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Evaluation of networks of randomized trials. Stat Methods Med Res (2007) 4.70
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol (2002) 4.30
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med (2013) 4.02
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ (2006) 3.47
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19
Recent developments in meta-analysis. Stat Med (2008) 2.97
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72
Graphical tools for network meta-analysis in STATA. PLoS One (2013) 2.66
Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute. J Clin Epidemiol (2013) 2.59
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol (2009) 2.26
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer (2005) 2.16
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet (2005) 2.09
Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med (2009) 2.09
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol (2011) 1.97
Conceptual and technical challenges in network meta-analysis. Ann Intern Med (2013) 1.92
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med (2005) 1.71
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol (2008) 1.71
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64
Hygiene and health: systematic review of handwashing practices worldwide and update of health effects. Trop Med Int Health (2014) 1.63
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60
Inherited cardiomyopathies. BMJ (2011) 1.55
The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol (2010) 1.49
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol (2011) 1.42
Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. Epidemiology (2017) 1.38
Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco. Cochrane Database Syst Rev (2015) 1.37
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev (2014) 1.36
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med (2006) 1.35
The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One (2013) 1.32
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. Stat Med (2012) 1.23
A design-by-treatment interaction model for network meta-analysis with random inconsistency effects. Stat Med (2014) 1.21
STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol (2009) 1.13
STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med (2009) 1.11
Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods. Stat Med (2008) 1.10
Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol (2010) 1.10
Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium. Stat Med (2007) 1.09
Bayesian multivariate meta-analysis with multiple outcomes. Stat Med (2013) 1.08
Planning future studies based on the conditional power of a meta-analysis. Stat Med (2012) 1.05
Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol (2012) 1.01
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol (2007) 1.01
Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med (2014) 0.98
Systematic review of birth prevalence of neural tube defects in India. Birth Defects Res A Clin Mol Teratol (2013) 0.98
Systematic review of controlled trials on the effectiveness of fluoride gels for the prevention of dental caries in children. J Dent Educ (2003) 0.97
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. Cochrane Database Syst Rev (2015) 0.96
The use of a Toolkit for health needs assessment on neural tube defects in Argentina. J Community Genet (2012) 0.95
Response to paper by Lang A, Edwards N, and Fleiszer A. J Clin Epidemiol (2007) 0.95
Meta-analysis and subgroups. Prev Sci (2013) 0.95
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study. BMJ (2009) 0.93
Meta-analysis of genetic association studies under different inheritance models using data reported as merged genotypes. Stat Med (2008) 0.91
Online genetic databases informing human genome epidemiology. BMC Med Res Methodol (2007) 0.91
Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study. BMJ (2011) 0.90
Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models. Stat Med (2008) 0.90
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis. Stat Med (2014) 0.88
Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatibility complex haplotype for psoriasis in a Caucasian population. J Invest Dermatol (2005) 0.86
Summarising and validating test accuracy results across multiple studies for use in clinical practice. Stat Med (2015) 0.85
Comments on 'Empirical vs natural weighting in random effects meta-analysis'. Stat Med (2010) 0.83
Cognitive-behavioural interventions for children who have been sexually abused. Cochrane Database Syst Rev (2012) 0.83
HLA-C, CSTA and DS12346 susceptibility alleles confer over 100-fold increased risk of developing psoriasis: evidence of gene interaction. J Hum Genet (2011) 0.82
Meta-analysis in occupational epidemiology: a review of practice. Occup Med (Lond) (2004) 0.82
Relative efficacy of differential methods of dietary advice: a systematic review. Am J Clin Nutr (2003) 0.82
Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study. BMC Med Res Methodol (2014) 0.82
WITHDRAWN: Opioids for the palliation of breathlessness in advanced disease and terminal illness. Cochrane Database Syst Rev (2012) 0.80
The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia. Eur Neuropsychopharmacol (2013) 0.80
Two-stage meta-analysis of survival data from individual participants using percentile ratios. Stat Med (2012) 0.80
Parent-infant psychotherapy for improving parental and infant mental health. Cochrane Database Syst Rev (2015) 0.79
Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene-gene-environment interaction. Stat Med (2006) 0.79
Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5. Eur J Hum Genet (2008) 0.78
Linear inference for mixed treatment comparison meta-analysis: a two-stage approach. Res Synth Methods (2012) 0.77
Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. J Inherit Metab Dis (2014) 0.77
Assessment of systematic effects of methodological characteristics on candidate genetic associations. Hum Genet (2012) 0.77
Health needs assessment for congenital anomalies in middle-income countries: Examining the case for neural tube defects in Brazil. J Community Genet (2013) 0.77
The association between proximity to animal-feeding operations and community health: a protocol for updating a systematic review. Syst Rev (2014) 0.76
Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal? Evid Based Ment Health (2009) 0.75
Gemcitabine upregulates ABCG2/BCRP and modulates the intracellular pharmacokinetic profiles of bioluminescence in pancreatic cancer cells. Anticancer Drugs (2016) 0.75
Atomic hydrogen adsorption and incipient hydrogenation of the Mg(0001) surface: a density-functional theory study. J Chem Phys (2009) 0.75
Hybridized doxorubicin-Au nanospheres exhibit enhanced near-infrared surface plasmon absorption for photothermal therapy applications. Nanoscale (2015) 0.75
Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study. Am J Epidemiol (2017) 0.75
Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). Br J Haematol (2010) 0.75
Group-based parent training programmes for improving emotional and behavioural adjustment in young children. Cochrane Database Syst Rev (2016) 0.75